Approved with
the understanding that BLS will draw a probability sample of 22,000
(in 30 panels) of which a sample of 7,500 will be surveyed as
described in the clearance request. BLS will monitor survey returns
on a weekly basis to determine the stability of mean values and for
the purpose of identifying the need for supplementation of cells.
BLS will brief OMB during August or early September 1988 on its
assessment of survey returns to date and its plans, if any, to
expand the basic survey through supplemental interviews to be
conducted through November 1988. To complete the current review
docket BLS will submit for OMB approval prior to use, revised
questions and a letter to respondents explaining the second stage
survey about one week in advance of the telephone call.
Inventory as of this Action
Requested
Previously Approved
12/31/1988
12/31/1988
6,000
0
0
1,375
0
0
0
0
0
THIS SURVEY WILL COLLECT INFORMATION
ON THE PREVALENCE OF DRUG TESTING AND REHABILITATION PROGRAMS AND
THE NUMBER OF EMPLOYEES DIRECTLY AFFECTED AT ESTABLISHMENTS ACROSS
THE PRIVATE SECTOR OF THE U.S. ECONOMY. THE RESULTS WILL PROVIDE
ESTIMATES AND MEASURES OF RELIABILITY OF THESE CHARACTERISTICS FOR
LIMITED INDUSTRY, GEOGRAPHY AND ESTABLISHMENT SIZE DETAIL.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.